Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Falling Comet
190.6500 -6.38 (-3.24%)
NSE Aug 01, 2025 15:31 PM
Volume: 5.0M
 

190.65
-3.24%
ICICI Securities Limited
Piramal Pharma’s Q1FY25 result was driven by better traction in innovative CDMO portfolio (50% of CDMO sales). Q1 is a seasonally weak quarter due to which its margins (10.5% in Q1FY25 vs 20.8% in Q4FY24) are volatile.
Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
More from Piramal Pharma Ltd.
Recommended